SCHEMBL2783602

SCHEMBL2783602

COC(=O)c1nc2cnc(Cl)nc2s1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
KMT2A Q03164 3/20 0.39
DYRK1A Q13627 2/20 0.38
DYRK1B Q9Y463 1/20 0.38
KDM4E B2RXH2 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PKM P14618 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ATF1 P18846 1/20 0.34
NFKB1 P19838 1/20 0.34
RCE1 Q9Y256 1/20 0.34
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
GLO1 Q04760 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25223823 0.73 MAPK1 (0.43) ALDH1A1KMT2ADYRK1ADYRK1BKDM4E
SCHEMBL30806799 0.73 CSNK2A2 (0.44) ALDH1A1KMT2AKDM4ESMN1; SMN2PKM
SCHEMBL1558803 0.73 DYRK1A (0.50) KMT2ADYRK1ASMN1; SMN2MAPTMEN1
SCHEMBL24960020 0.71 ALDH1A1 (0.60) ALDH1A1KMT2AKDM4ESMN1; SMN2L3MBTL1
SCHEMBL23290833 0.71 ADORA3 (0.37) ALDH1A1KMT2ADYRK1AKDM4ESMN1; SMN2
SCHEMBL2368279 0.71 ATM (0.47) ALDH1A1KDM4ESMN1; SMN2MAPTRXFP1
SCHEMBL557710 0.70 SMN1; SMN2 (0.54) ALDH1A1KMT2AKDM4ESMN1; SMN2NFKB1
SCHEMBL31119726 0.70 LCK (0.46)
SCHEMBL19296321 0.70 GAA (0.39) ALDH1A1KDM4ESMN1; SMN2PKMMAPT
SCHEMBL2179164 0.69 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197692-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. 2010-08-05 US disclosed
EP-2178884-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Frosst Canada Ltd. (CA) 2010-04-28 EP disclosed
WO-2009012573-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197692-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, CPT1A ALDH1A1 623/4885KMT2A 3301/4885DYRK1A 3550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.